Self-management of buprenorphine/naloxone among online discussion board users

Substance Use and Misuse

Volumn 49, Issue 8, 2014, Pages 1017-1024

  Brown, Shan Estelle ^a   Altice, Frederick L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Buprenorphine; Discussion board; Diversion; Internet; Naloxone; Self treatment

Indexed keywords

BUPRENORPHINE; NALOXONE; NARCOTIC ANTAGONIST;

HUMAN; OPIOID-RELATED DISORDERS; QUALITATIVE RESEARCH; RETROSPECTIVE STUDY; SELF CARE; SOCIAL MEDIA; SOCIAL SUPPORT;

BUPRENORPHINE; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; QUALITATIVE RESEARCH; RETROSPECTIVE STUDIES; SELF CARE; SOCIAL MEDIA; SOCIAL SUPPORT;

EID: 84899750908     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2014.888449     Document Type: Article

References (46)

1. Altice, F. L.,Mostashari, F., & Friedland, G. H. (2001). Trust and the acceptance of and adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 28(1), 47-58
2. Altice, F. L., Sullivan, L. E., Smith-Rohrberg, D., Basu, S., Stancliff, S., & Eldred, L. (2006). The potential role of buprenorphine in the treatment of opioid dependence in HIV-Infected individuals and in HIV Infection Prevention. Clinical Infectious Diseases, 43(Suppl. 4), S178-S183
3. Amato, L., Davoli, M., Perucci, C. A., Ferri, M., Faggiano, F., & Mattick, R. P. (2005). An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Availableevidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28(4), 321-329
4. Baker, L., Wagner, T. H., Singer, S., & Bundorf, M. (2003). Use of the internet and e-mail for health care information: Results from a national survey. JAMA: The Journal of The American Medical Association, 289(18), 2400-2406
5. Barney, L. J., Griffiths, K. M., & Banfield, M. A. (2011). Explicit and implicit information needs of people with depression: A qualitative investigation of problems reported on an online depression support forum. Bmc Psychiatry, 11(88). doi:10.1186/1471-244X-11-88
6. Barratt, M. J., & Lenton, S. (2010). Beyond recruitment? Participatory online research with people who use drugs. International Journal of Internet Research Ethics, 3, 69-86
7. Bazazi, A. R., Yokell, M., Fu, J. J., Rich, J. D., & Zaller, N. D. (2011). Illicit use of Buprenorphine/Naloxone among injecting and noninjecting Opioid users. Journal of Addiction Medicine, 5(3), 175-180
8. Bell, J. (2010). The Global Diversion of Pharmaceutical Drugs. Addiction, 105(9), 1531-1537
9. Boyer, E. W., Babu, K. M., Macalino, G. E., & Compton, W. (2007). Self-Treatment of opioid withdrawal with a dietary supplement, Kratom. The American Journal on Addictions, 16(5), 352-356
10. Cunningham, C. O., Giovanniello, A., Li, X., Kunins, H. V., Roose, R. J., & Sohler, N. L. (2011). A comparison of buprenorphine induction strategies: Patient-centered home-based inductions versus standard-of-care office-based inductions. Journal of Substance Abuse Treatment, 40(4), 349-356
11. Daniulaityte, R., Falck, R., & Carlson, R. G. (2012a). Illicit use of buprenorphine in a community sample of young adult nonmedical users of pharmaceutical opioids. Drug and Alcohol Dependence, 122(3), 201-207
12. Daniulaityte, R., Falck, R., & Carlson, R. G. (2012b). I'm not afraid of those ones just 'cause they've been prescribed: Perceptions of risk among illicit users of pharmaceutical opioids. International Journal of Drug Policy, 23(5), 374-384
13. Daniulaityte, R., Falck, R. S.,Wang, J., & Carlson, R. G. (2009). Illicit use of pharmaceutical opioids among young polydrug users in Ohio. Addictive Behaviors, 34(8), 649-653
14. Dasgupta, N., Bailey, E. J., Cicero, T., Inciardi, J., Parrino, M., Rosenblum, A., . . . Dart, R. C. (2010). Post-marketing Surveillance of Methadone and Buprenorphine in the United States. Pain Medicine, 11(7), 1078-1091
15. Daulouede, J. P., Caer, Y., Galland, P., Villeger, P., Brunelle, E., Bachellier, J., . . . Courty, P. (2010). Preference for buprenorphine/ naloxone and buprenorphine among patients receiving buprenorphine maintenance therapy in France: A prospective, multicenter study. Journal of Substance Abuse Treatment, 38(1), 83-89
16. Dennis, M., & Scott, C. K. (2007).Managing addiction as a chronic condition. Addiction Science & Clinical Practice, 4(1), 45-55
17. Denzin, N. K., & Lincoln, Y. S. (2003). Strategies of qualitative inquiry. New Delhi: SAGE Publications
18. Egan, J. E., Netherland, J., Gass, J., Finkelstein, R., Weiss, L., & Collaborative, f. t. B. (2011). Patient perspectives on Buprenorphine/Naloxone Treatment in the context of HIV care. JAIDS Journal of Acquired Immune Deficiency Syndromes, 56, S46-S53 10.1097/QAI.1090b1013e3182097561
19. Eichenberg, C. (2008). Internet message boards for suicidal people: A typology of users. Cyberpsychology & Behavior, 11(1), 107-113
20. Eysenbach, G., & Till, J. E. (2001). Ethical issues in qualitative research on internet communities. British Medical Journal, 323(7321), 1103-1105
21. Haddad, M. S., Zelenev, A., & Altice, F. L. (2013). Integrating buprenorphine maintenance therapy into federally qualified health centers: Real-world substance abuse treatment outcomes. Drug Alcohol Dependence, 131(1-2), 127-135
22. Hadert, A., & Rodham, K. (2008). The invisible reality of arthritis: A qualitative analysis of an online message board. Musculoskeletal Care, 6(3), 181-196
23. Jodlowski, D., Sharf, B F., Nguyen, L. C., Haidet, P., & Woodard, L. D. (2007). 'Screwed for life': Examining identification and division in addiction narratives. Communication&Medicine, 4(1), 15-26
24. Johnson, G., Zastawny, S., & Kulpa, A. (2010). E-message boards for those who self-injure: Implications for E-health. International Journal of Mental Health and Addiction, 8(4), 566-569
25. Kenen, R. H., Shapiro, P. J., Friedman, S., & Coyne, J. C. (2007). Peer-support in coping with medical uncertainty: Discussion of oophorectomy and hormone replacement therapy on a web-based message board. Psycho-Oncology, 16(8), 763-771
26. Larance, B.,Degenhardt, L., Lintzeris, N.,Winstock, A., & Mattick, R. (2011). Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non-Adherence and aberrant medication-related behaviours. Drug and Alcohol Review, 30(3), 236-245
27. Ling, W., Casadonte, P., Bigelow, G., Kampman, K. M., Patkar, A., Bailey, G. L., . . . Beebe, K. L. (2010). Buprenorphine implants for treatment of opioid dependence: A randomized controlled trial. Journal of the American Medical Association, 304(14), 1576-1583
28. Maremmani, I. (2008). When a new drug promotes the integration of treatment modalities: Suboxone and harm reduction. Heroin Addiction and Related Clinical Problems, 10(3), 5-11
29. Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008). Buprenorphine maintenance versus placebo ormethadone maintenance for opioid dependence. Cochrane Database System Review, 16(2), CD002207
30. Miller, J. (2007). The other side of trust in health care: Prescribing drugs with the potential for abuse. Bioethics, 21(1), 51-60
31. Moratti, E., Kashanpour, H., Lombardelli, T., & Maisto, M. (2010). Intravenous misuse of Buprenorphine characteristics and extent among patients undergoing drug maintenance therapy. Clinical Drug Investigation, 30, 3-11
32. Morden, A., Jinks, C., & Ong, B. N. (2012). Rethinking 'risk' and self-management for chronic illness. Social Theory & Health, 10, 78-99
33. Murgúia, E., Tackett-Gibson, M., & Lessem, A. (2007). Real Drugs in a Virtual World: Drug Discourse and Community Online. Lanham, MD: Lexington Books
34. Nambisan, P. (2011). Information seeking and social support in online health communities: Impact on patients' perceived empathy. Journal of the American Medical Informatics Association, 18(3), 298-304
35. Orizio, G., Schulz, P., Gasparotti, C., Caimi, L., & Gelatti, U. (2010). The World of e-patients: A content analysis of online social networks focusing on diseases. Telemedicine Journal and E-Health, 16(10), 1060-1066
36. Ostertag, S., Wright, B. R. E., Broadhead, R. S., & Altice, F. L. (2006). Trust and other characteristics associated with health care utilization by injection drug users. Journal of Drug Issues, 36(4), 953-974
37. Schultz, P. N., Stava, C., Beck, M. L., & Vassilopoulou-Sellin, R. (2003). Internet message board use by patients with cancer and their families. Clinical Journal of Oncology Nursing, 7(6), 663-667
38. Schuman-Olivier, Z., Albanese, M., Nelson, S. E., Roland, L., Puopolo, F.,Klinker, L., . . . Shaffer, H. J. (2010). Self-Treatment: Illicit buprenorphine use by opioid-dependent treatment seekers. Journal of Substance Abuse Treatment, 39(1), 41-50
39. Sohler, N. L., Li, X., Kunins, H. V., Sacajiu, G., Giovanniello, A., Whitley, S., . . . Cunningham, C. O. (2010).Home-versus officebased buprenorphine inductions for opioid-dependent patients. Journal of Substance Abuse Treatment, 38(2), 153-159
40. Stanos, S. P., Bruckenthal, P., & Barkin, R. L. (2012). Strategies to reduce the tampering and subsequent abuse of long-Acting opioids: Potential risks and benefits of formulations with physical or pharmacologic deterrents to tampering. Mayo Clinic Proceedings, 87(7), 683-694
41. Stimmel, B. (2011). Buprenorphine in the treatment of Heroin Addiction: D́ejà Vu all over again. Journal of Addictive Diseases, 31(1), 1-2
42. Strain, E. C., Harrison, J. A., & Bigelow, G. E. (2011). Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/ naloxone soluble-films. Clinical Pharmacology & Theraputics, 89(3), 443-449
43. Vicknasingam, B., Mazlan, M., Schottenfeld, R. S., & Chawarski, M. C. (2010). Injection of buprenorphine and buprenorphine/ naloxone tablets in Malaysia. Drug and Alcohol Dependence, 111(1-2), 44-49
44. Walker, D., & Myrick, F. (2006). Grounded theory: An exploration of process and procedure. Qualitative Health Research, 16(4), 547-559
45. Wen, K. Y., McTavish, F., Kreps, G., Wise, M., & Gustafson, D. (2011). From diagnosis to death: A case study of coping with breast cancer as seen through online discussion group messages. Journal of Computer-Mediated Communication, 16(2), 331-361
46. Wish, E. D., Artigiani, E., Billing, A., Hauser, W., Hemberg, J., Shiplet, M., . . . DuPont, R. L. (2012). The Emerging Buprenorphine Epidemic in the United States. Journal of Addictive Diseases, 31(1), 3-7